The Nordic Mentor Network for Entrepreneurship (NOME) is an elite Nordic Mentoring Program for promising life science projects and startups, driven by the vision of transforming Nordic life science startups into internationally renowned commercial successes. This is done by matching selected Nordic startups with highly skilled volunteer professionals to help them reach their goals and technology milestones.

At the University of Connecticut (UCONN) students, faculty, and staff seek to improve the world around them through innovation, meeting societal needs with novel solutions for products, services, and processes. The Peter J. Werth Institute for Entrepreneurship and Innovation at UCONN links the multitude of ways students can learn and practice entrepreneurship at the University, unlocking an innovative mindset in every student and instilling an inquisitive approach to rejecting the status quo.

Chief Legal Officer at Pharvaris, a clinical-stage life sciences company pioneering science for patient choice, specifically bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-mediated diseases. Headquartered in Zug, Switzerland, with hubs in the Greater Boston and Amsterdam areas, we have a culture built on the core values of caring, trust, diversity and freedom and is driven by individuals committed to developing breakthrough therapies that have real impact on people’s lives. Serve as Secretary to the Board of Directors.

Executive Vice President, General Counsel responsible for leading the legal, compliance and intellectual property functions at Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, which was acquired by Pfizer for $6.7 billion in March 2022, for its pipeline of potentially transformational medicines targeting a broad range of therapeutic areas including gastrointestinal, dermatologic and cardiovascular conditions. Served as Secretary to the Board of Directors and Executive Sponsor of Arena's Diversity & Inclusion Council.

Chief Legal Officer responsible for leading the Company’s legal, compliance and intellectual property functions at DBV Technologies, a global biopharmaceutical company advancing the treatment of food allergies, a condition that affects millions of people. DBV has developed a class of immunotherapy that aims to activate the immune system of patients through the skin. DBV seeks to potentially offer the first patch treatment for peanut allergy in children. Served as a member of the Executive Committee and Secretary to the Board of Directors.

Executive Vice President, Legal & Human Resources, General Counsel and Secretary at Biotronik, Inc., a leading manufacturer of cardio and endovascular medical devices. Headquartered in Berlin, Biotronik has over 6,000 employees globally in more than 100 countries, and production and research and development facilities in Germany, Switzerland, Singapore and the US. Served as a member of Executive Management with responsibility for all US legal and HR matters.

Deputy to Global General Counsel at Novo Nordisk, a Fortune 100 life sciences company with 45,000 employees, turnover of $15 billion and products marketed in 180 countries. Advised Executive Management and Board of Directors on strategic matters, key corporate transactions and material risks to the company. Senior member of the Global Legal Board, which provides strategic direction for 140+ legal and compliance professionals in 27 countries. Globally responsible for legal risk management, internal control and external counsel management with line management of three departments: M&A and IP licensing, litigation/dispute resolution and trademarks.Acted as an internal Business Assurance Consultant to conduct management audits globally and provide recommendations to senior management to improve organizational effectiveness, business performance and compliance with the company’s leadership values and management practices.

Vice President with global responsibility for litigations, investigations and alternative dispute resolution involving products liability, intellectual property, unfair trade practices and FCPA, FCA and anti-kickback issues; corporate transactions including M&A, intellectual property licensing and strategic alliances; intellectual property, specificallly protection and enforcement of trademark/domain name rights and development of anti-counterfeiting strategies.

Assistant General Counsel for North American healthcare business with turnover of $1 billion and approximately 1,500 employees, advising on matters relating to contracts, corporate governance, litigation, drug advertising, promotion and pricing, and employment law. One-year secondment to corporate headquarters in Denmark (2003-2004).

Assistant General Counsel (1999-2002) for the holding company of Novo Nordisk’s US subsidiaries, which consisted of a industrial biotechnology business (now Novozymes) supplying solutions to textile, detergent, food and agriculture companies to increase industrial efficiency and a healthcare business focused on the sales and marketing of products for the treatment of diabetes, hemophilia and growth disorders until the company demerged in 2000. Senior Corporate Counsel (1997-98); Corporate Counsel (1995-96)

Associate in the Commercial Litigation Group of a mid-size, multi-disciplinary firm known for its highly regarded government relations practice. Conducted general litigation practice in state and federal courts, involving complex corporate, contractual, bankruptcy and employment issues. Paralegal (1990-91) concurrent with law school.